Abstract
Epidermal growth factor receptor inhibitors are the research focus in the molecular targeted therapy of lung cancer. Epidermal growth factor receptor inhibitors have been widely used for the treatment of non-small cell lung cancer. In recent years, it has been found that epidermal growth factor receptor mutation and its inhibitors are closely related to the clinical efficacy. This article reviews the research progress of epidermal growth factor receptor inhibitors and its mutation in the therapy of lung cancer. Key words: Epidermal growth factor receptor; Gene mutation; Lung cancer
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
